Masaki Terabe, Ph.D.

    Masaki  Terabe, Ph.D.
  
Associate Scientist
Vaccine Branch
Dr. Terabe's research focus is on elucidating the mechanisms of immune regulation of tumor immunity, in particular roles of regulatory cells including natural killer (NK) T cells, regulatory T cells and myeloid-lineage cells.
Areas of Expertisetumor immunity
        Contact Info          
Masaki  Terabe, Ph.D.

Center for Cancer Research

National Cancer Institute

Building 10, Room 6B12

Bethesda, MD 20892

Ph: 240-760-6731
terabe@mail.nih.gov
Permalink
  
Research
Publications
Biography
Dr. Terabe's research focus is on elucidating the mechanisms of immune regulation of tumor immunity, in particular roles of regulatory cells including natural killer (NK) T cells, regulatory T cells and myeloid-lineage cells.
Selected Publications
            Cancer vaccines: translation from mice to human clinical trials.  
                                                                                
        Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity.  
                                                                                
        Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy.  
                                                                                
        TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer.  
                                                                                
        NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.  
                                                                                
Dr. Terabe received his Ph.D. degree at Tokyo University, Japan.  He joined the Molecular Immunogenetics and Vaccine Research Section, Metabolism Branch, NCI in 1999 as a visiting fellow.  He became a research fellow in 2002 and a staff scientist in 2005.  In 2007, Dr. Terabe became an associate scientist and deputy section chief of Molecular Immunogenetics and Vaccine Research Section, Vaccine Branch, NCI.